These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7699617)

  • 1. Antiperinuclear factor and disease activity in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
    Kerstens PJ; Boerbooms AM; Jeurissen ME; Westgeest TA; Van Erp A; Mulder J; van de Putte LB
    J Rheumatol; 1994 Dec; 21(12):2190-4. PubMed ID: 7699617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical heterogeneity of rheumatoid arthritis and the antiperinuclear factor.
    Manera C; Franceschini F; Cretti L; Braga S; Cattanec R
    J Rheumatol; 1994 Nov; 21(11):2021-5. PubMed ID: 7869304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of azathioprine and methotrexate in rheumatoid arthritis: an open-randomized clinical study].
    Westedt ML; Dijkmans BA; Hermans J
    Rev Rhum Ed Fr; 1994 Oct; 61(9):591-7. PubMed ID: 7858592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis.
    Westgeest AA; Boerbooms AM; Jongmans M; Vandenbroucke JP; Vierwinden G; van de Putte LB
    J Rheumatol; 1987 Oct; 14(5):893-7. PubMed ID: 3501470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low dose methotrexate therapy on the concentration and the glycosylation of alpha 1-acid glycoprotein in the serum of patients with rheumatoid arthritis: a longitudinal study.
    De Graaf TW; Van Ommen EC; Van der Stelt ME; Kerstens PJ; Boerbooms AM; Van Dijk W
    J Rheumatol; 1994 Dec; 21(12):2209-16. PubMed ID: 7699621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
    Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE
    J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine and methotrexate as combination chemotherapy in rheumatoid arthritis.
    McKendry RJ
    J Rheumatol Suppl; 1990 Nov; 25():28-33. PubMed ID: 2273519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiperinuclear factor as a prognostic marker in rheumatoid arthritis.
    Muñoz-Fernández S; Alvarez-Doforno R; González-Tarrio JM; Balsa A; Richi P; Fontán G; Gijón-Baños J; Martin-Mola E
    J Rheumatol; 1999 Dec; 26(12):2572-7. PubMed ID: 10606364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process.
    Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M
    J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
    De Rycke L; Kruithof E; Van Damme N; Hoffman IE; Van den Bossche N; Van den Bosch F; Veys EM; De Keyser F
    Arthritis Rheum; 2003 Apr; 48(4):1015-23. PubMed ID: 12687543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
    Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
    Visvanathan S; Wagner C; Smolen J; St Clair EW; Hegedus R; Baker D; Keenan G
    Arthritis Rheum; 2006 Sep; 54(9):2840-4. PubMed ID: 16948115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
    Maini RN; Breedveld FC; Kalden JR; Smolen JS; Davis D; Macfarlane JD; Antoni C; Leeb B; Elliott MJ; Woody JN; Schaible TF; Feldmann M
    Arthritis Rheum; 1998 Sep; 41(9):1552-63. PubMed ID: 9751087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis.
    Zhang LL; Wei W; Xiao F; Xu JH; Bao CD; Ni LQ; Li XF
    Arthritis Rheum; 2008 Jul; 59(7):905-10. PubMed ID: 18576295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine.
    Kerstens PJ; Boerbooms AM; Jeurissen ME; de Graaf R; Mulder J; van de Putte LB
    J Rheumatol; 2000 May; 27(5):1148-55. PubMed ID: 10813280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of relationship between the Epstein-Barr virus and the antiperinuclear factor/'perinuclear antigen' system in rheumatoid arthritis.
    Buisson M; Berthelot JM; Le Goff P; Chastel C; Lamour A; Seigneurin JM; Youinou P
    J Autoimmun; 1994 Aug; 7(4):485-95. PubMed ID: 7980850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.